江苏蓝丰生物化工股份有限公司关于2025年限制性股票激励计划授予登记完成的公告

Core Viewpoint - The announcement details the completion of the 2025 restricted stock incentive plan by Jiangsu Lanfeng Biological Chemical Co., Ltd, including the number of shares granted, the recipients, and the conditions for vesting and performance assessment [1][19]. Group 1: Stock Grant Details - The number of restricted shares granted is 20.03 million, accounting for 5.63% of the company's total shares before the grant [1][7]. - The grant date for the restricted shares is November 24, 2025, with the shares set to be listed on December 8, 2025 [6][16]. - The grant price for the restricted shares is set at 2.64 yuan per share [7]. Group 2: Recipients and Approval Process - A total of 71 individuals are designated as recipients of the restricted shares, including senior management, middle management, and key employees [2][7]. - The decision-making process involved multiple board meetings and approvals, with legal opinions provided by Beijing Wanshang Tianqin Law Firm [3][5]. Group 3: Vesting Conditions - The vesting period for the restricted shares is set at 12 months and 24 months from the date of grant, during which the shares cannot be transferred or used as collateral [8][9]. - Performance assessment for the vesting of shares will be based on company-level and individual-level criteria over the years 2025 and 2026 [10][12]. Group 4: Financial Impact - The total number of shares after the grant will increase from 355.56 million to 375.59 million, affecting the shareholding structure of major shareholders [17][19]. - The incentive plan is expected to raise approximately 52.88 million yuan, which will be used to supplement working capital [15][17]. Group 5: Compliance and Reporting - The company has confirmed that there were no stock trading activities by participating directors and senior management in the six months prior to the grant [18]. - The company will continue to monitor shareholder equity changes and comply with relevant disclosure obligations [19].